Rotational Stability Analysis of a Toric Monofocal IOL (PHY2013)
Primary Purpose
Cataract, Lens Opacities, Astigmatism
Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
IOL implantation experimental
Sponsored by
About this trial
This is an interventional treatment trial for Cataract focused on measuring Intraocular Lens, Monofocal, Toric Lens
Eligibility Criteria
Inclusion Criteria:
- Cataracteous Eyes with no comorbidity
- Regular corneal astigmatism >1 dioptre and <3D determined by an automatic keratometer (regularity determined by the topography of the keratometry).
- Availability, willingness and sufficient cognitive awareness to comply with examination procedures
- Signed informed consent •>50 years old
Exclusion Criteria:
- Acute or chronic disease or illness that would increase risk or confound study results (e.g. diabetes mellitus (with retinopathy), immunocompromised, glaucoma etc…)
- Any ocular comorbidity
- History of ocular trauma or prior ocular surgery including refractive procedures
- Capsule or zonular abnormalities that may affect postoperative centration or tilt of the lens (e.g. pseudoexfoliation syndrome, Marfan's syndrome)
- Pupil abnormalitis (non-reactive, tonic pupils, abnormally shaped pupils or pupils that do not dilate under mesopic/scotopic conditions)
Sites / Locations
- Ruhr-Universitat Bochum, Bochum, Germany
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Ankoris IOL Implantation experimental
Arm Description
Monolateral implantation of toric intraocular lenses Ankoris
Outcomes
Primary Outcome Measures
Rotational stability - Photograph of IOL with dilated pupil to asses IOL rotation
Rotational stability of the ANKORIS is evaluated on the basis of slit-lamp photographies to capture the iris and the marks onto the lens. Descriptive statistics will be used to determine the IOL stability.
Secondary Outcome Measures
Residual astigmatism after Ankoris implantation with respect to the targeted astigmatism correction.
Visual performance is determined in terms of monocular uncorrected distance visual acuity (UDVA), distance corrected visual acuity (DCVA) and postoperative refraction. Efficiency will be assessed using Alpins method.
Full Information
NCT ID
NCT04933487
First Posted
June 18, 2021
Last Updated
June 18, 2021
Sponsor
Beaver-Visitec International, Inc.
Collaborators
targomedGmbH
1. Study Identification
Unique Protocol Identification Number
NCT04933487
Brief Title
Rotational Stability Analysis of a Toric Monofocal IOL
Acronym
PHY2013
Official Title
Prospective Evaluation of the Rotational Stability of the Ankoris Intraocular Lens
Study Type
Interventional
2. Study Status
Record Verification Date
June 2021
Overall Recruitment Status
Completed
Study Start Date
August 26, 2014 (Actual)
Primary Completion Date
January 1, 2016 (Actual)
Study Completion Date
March 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Beaver-Visitec International, Inc.
Collaborators
targomedGmbH
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This is a single-center, prospective PMCF study whereby patients undergoing routine cataract surgery will have monolateral implantation of hydrophilic monofocal toric intraocular lens Ankoris.
Detailed Description
This is a single-center, prospective, nonrandomized PMCF study whereby patients undergoing routine cataract surgery will have monolateral implantation of hydrophilic monofocal toric intraocular lens (Ankoris). The device under investigation is manufactured by the sponsor of this study. The refractive power of the lens has a spherical and a cylindrical component. The IOLs will be implanted in the course of routine cataract surgery and will benefit to patients suffering from cataract development and showing pre-existing corneal astigmatism.
The primary objective of this study is to determine the rotational stability of the Ankoris intraocular lens. The secondary objective is to measure the residual astigmatism after Ankoris implantation with respect to the targeted astigmatism correction.
In total approx. 20 eyes of 20 patients will be recruited for this clinical study.
Follow-ups will be performed 1 day, 1 month, and 3 months after cataract surgery. Subjects would have the option for unscheduled visits if required medically.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cataract, Lens Opacities, Astigmatism
Keywords
Intraocular Lens, Monofocal, Toric Lens
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
23 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Ankoris IOL Implantation experimental
Arm Type
Experimental
Arm Description
Monolateral implantation of toric intraocular lenses Ankoris
Intervention Type
Device
Intervention Name(s)
IOL implantation experimental
Intervention Description
Monolateral implantation of toric intraocular lenses Ankoris. (Manufactured by PhysIOL sa/nv, Liège, Belgium).
Primary Outcome Measure Information:
Title
Rotational stability - Photograph of IOL with dilated pupil to asses IOL rotation
Description
Rotational stability of the ANKORIS is evaluated on the basis of slit-lamp photographies to capture the iris and the marks onto the lens. Descriptive statistics will be used to determine the IOL stability.
Time Frame
3 months postoperative
Secondary Outcome Measure Information:
Title
Residual astigmatism after Ankoris implantation with respect to the targeted astigmatism correction.
Description
Visual performance is determined in terms of monocular uncorrected distance visual acuity (UDVA), distance corrected visual acuity (DCVA) and postoperative refraction. Efficiency will be assessed using Alpins method.
Time Frame
Follow-ups will be performed 1 day, 1 month, and 3 months after cataract surgery
10. Eligibility
Sex
All
Minimum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Cataracteous Eyes with no comorbidity
Regular corneal astigmatism >1 dioptre and <3D determined by an automatic keratometer (regularity determined by the topography of the keratometry).
Availability, willingness and sufficient cognitive awareness to comply with examination procedures
Signed informed consent •>50 years old
Exclusion Criteria:
Acute or chronic disease or illness that would increase risk or confound study results (e.g. diabetes mellitus (with retinopathy), immunocompromised, glaucoma etc…)
Any ocular comorbidity
History of ocular trauma or prior ocular surgery including refractive procedures
Capsule or zonular abnormalities that may affect postoperative centration or tilt of the lens (e.g. pseudoexfoliation syndrome, Marfan's syndrome)
Pupil abnormalitis (non-reactive, tonic pupils, abnormally shaped pupils or pupils that do not dilate under mesopic/scotopic conditions)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Burkhard Dick, MD
Organizational Affiliation
Ruhr-Universitat Bochum, Bochum, Germany
Official's Role
Principal Investigator
Facility Information:
Facility Name
Ruhr-Universitat Bochum, Bochum, Germany
City
Bochum
Country
Germany
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Rotational Stability Analysis of a Toric Monofocal IOL
We'll reach out to this number within 24 hrs